156 related articles for article (PubMed ID: 18249302)
1. Transglutaminase and the pathogenesis of coeliac disease.
Stenberg P; Roth EB; Sjöberg K
Eur J Intern Med; 2008 Mar; 19(2):83-91. PubMed ID: 18249302
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease.
Stenberg P; Roth B; Wollheim FA
Eur J Intern Med; 2009 Dec; 20(8):749-55. PubMed ID: 19892302
[TBL] [Abstract][Full Text] [Related]
3. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
4. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease.
Skovbjerg H; Norén O; Anthonsen D; Moller J; Sjöström H
Scand J Gastroenterol; 2002 Jul; 37(7):812-7. PubMed ID: 12190095
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 in celiac disease: minireview article.
Caputo I; D'Amato A; Troncone R; Auricchio S; Esposito C
Amino Acids; 2004 Jul; 26(4):381-6. PubMed ID: 15290344
[TBL] [Abstract][Full Text] [Related]
6. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies.
Caja S; Myrsky E; Korponay-Szabo IR; Nadalutti C; Sulic AM; Lavric M; Sblattero D; Marzari R; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
Scand J Gastroenterol; 2010 Apr; 45(4):421-7. PubMed ID: 20095873
[TBL] [Abstract][Full Text] [Related]
8. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease?
Lindfors K; Kaukinen K; Mäki M
Amino Acids; 2009 Apr; 36(4):685-91. PubMed ID: 18594945
[TBL] [Abstract][Full Text] [Related]
9. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
Bodil Roth E; Theander E; Londos E; Sandberg-Wollheim M; Larsson A; Sjöberg K; Stenberg P
Scand J Immunol; 2008 Jun; 67(6):626-31. PubMed ID: 18476880
[TBL] [Abstract][Full Text] [Related]
11. The function of tissue transglutaminase in celiac disease.
Di Sabatino A; Vanoli A; Giuffrida P; Luinetti O; Solcia E; Corazza GR
Autoimmun Rev; 2012 Aug; 11(10):746-53. PubMed ID: 22326684
[TBL] [Abstract][Full Text] [Related]
12. Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease.
Vetrano S; Zampaletta U; Anania MC; Di Tola M; Sabbatella L; Passarelli F; Maffia C; Sanjust MG; Lettieri F; De Pità O; Picarelli A
Dig Liver Dis; 2007 Oct; 39(10):911-6. PubMed ID: 17719860
[TBL] [Abstract][Full Text] [Related]
13. The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease.
Freitag T; Schulze-Koops H; Niedobitek G; Melino G; Schuppan D
Autoimmun Rev; 2004 Feb; 3(2):13-20. PubMed ID: 15003183
[TBL] [Abstract][Full Text] [Related]
14. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
[TBL] [Abstract][Full Text] [Related]
15. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
Dieterich W; Esslinger B; Trapp D; Hahn E; Huff T; Seilmeier W; Wieser H; Schuppan D
Gut; 2006 Apr; 55(4):478-84. PubMed ID: 16188922
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in celiac disease.
Alaedini A; Green PH
Autoimmunity; 2008 Feb; 41(1):19-26. PubMed ID: 18176861
[TBL] [Abstract][Full Text] [Related]
17. Genetic associations and immunopathogenesis of coeliac disease.
Pécsi G
Acta Physiol Hung; 2000; 87(4):339-53. PubMed ID: 11732888
[TBL] [Abstract][Full Text] [Related]
18. Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.
Paolella G; Sposito S; Romanelli AM; Caputo I
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886862
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of circulating tissue transglutaminase-specific T cells in coeliac disease.
Ciccocioppo R; Finamore A; Mengheri E; Millimaggi D; Esslinger B; Dieterich W; Papola F; Colangeli S; Tombolino V; Schuppan D; Corazza GR
Int J Immunopathol Pharmacol; 2010; 23(1):179-91. PubMed ID: 20377989
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver.
Elli L; Bergamini CM; Bardella MT; Schuppan D
Dig Liver Dis; 2009 Aug; 41(8):541-50. PubMed ID: 19195940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
